Fueling immune checkpoint blockade with oncolytic viruses: Current paradigms and challenges ahead.

Li, Shu-Jin; Sun, Zhi-Jun

Li, Shu-Jin; Sun, Zhi-Jun.

Afiliación

Li SJ; The State Key Laboratory Breeding Base of Basic Science of Stomatology (Hubei-MOST) & Key Laboratory of Oral Biomedicine Ministry of Education, School & Hospital of Stomatology, Wuhan University, 430079 Wuhan, China. Electronic address: lishujin@whu.edu.cn.
Sun ZJ; The State Key Laboratory Breeding Base of Basic Science of Stomatology (Hubei-MOST) & Key Laboratory of Oral Biomedicine Ministry of Education, School & Hospital of Stomatology, Wuhan University, 430079 Wuhan, China; Department of Oral Maxillofacial-Head Neck Oncology, School ï¼ and Hospital of Stomatology, Wuhan University, 430079 Wuhan, China. Electronic address: sunzj@whu.edu.cn.

Cancer Lett ; 550: 215937, 2022 12 01.

Article en En | MEDLINE | ID: mdl-36206966

Asunto(s)

Neoplasias; Viroterapia Oncolítica; Virus Oncolíticos; Antivirales/uso terapéutico; Humanos; Inhibidores de Puntos de Control Inmunológico; Neoplasias/tratamiento farmacológico; Virus Oncolíticos/fisiología

Palabras clave

Biomarker; Clinical trial; Immune checkpoint inhibitor; Systemic delivery; T-VEC

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Virus Oncolíticos / Viroterapia Oncolítica / Neoplasias Límite: Humans Idioma: En Revista: Cancer Lett Año: 2022 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google